ISIS Pharmaceuticals Cuts License Deal With Bayer AG By: Benzinga via Benzinga May 04, 2015 at 12:46 PM EDT Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) gained more than 3 percent after the company agreed to license its developmental ... Read More >> Related Stocks: Bayer Aktienges ADR